本页面由Tiger Trade Technology Pte. Ltd.提供服务

ADC Therapeutics SA

1.86
+0.13007.51%
盘后:1.85-0.0100-0.54%19:40 EDT
成交量:159.31万
成交额:280.57万
市值:2.38亿
市盈率:-2.56
高:1.87
开:1.70
低:1.64
收:1.73
52周最高:4.98
52周最低:0.7796
股本:1.28亿
流通股本:8,856.21万
量比:0.59
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-0.7271
每股收益(LYR):-1.1224
净资产收益率:-705.53%
总资产收益率:-19.57%
市净率:-1.04
市盈率(LYR):-1.66

数据加载中...

2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/04/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/21

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/16

SEC问询函

Form CORRESP - Correspondence
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership